- Report
- December 2022
- 439 Pages
Global
From €2271EUR$2,499USD£1,945GBP
€3245EUR$3,570USD£2,778GBP
- Report
- July 2022
- 256 Pages
Global
From €2271EUR$2,499USD£1,945GBP
€3245EUR$3,570USD£2,778GBP
- Report
- March 2022
- 157 Pages
Global
From €2362EUR$2,598USD£2,022GBP
€3374EUR$3,712USD£2,889GBP
- Report
- December 2021
- 224 Pages
Global
From €2362EUR$2,598USD£2,022GBP
€3374EUR$3,712USD£2,889GBP
- Report
- August 2021
- 187 Pages
Global
From €2362EUR$2,598USD£2,022GBP
€3374EUR$3,712USD£2,889GBP
- Report
- March 2021
- 172 Pages
Asia Pacific
From €2362EUR$2,598USD£2,022GBP
€3374EUR$3,712USD£2,889GBP
- Report
- February 2022
- 235 Pages
Global
From €2362EUR$2,598USD£2,022GBP
€3374EUR$3,712USD£2,889GBP
- Book
- April 2024
- 272 Pages
- Book
- July 2022
- 896 Pages
- Book
- May 2021
- 224 Pages
- Book
- November 2018
- 464 Pages
- Book
- March 2014
- 144 Pages
- Book
- September 2013
- 152 Pages
€2530EUR$2,982USD£2,242GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more